Early allo-SCT for AML with a complex aberrant karyotype--results from a prospective pilot study (Q34167404)

31 July 2017

title

Early allo-SCT for AML with a complex aberrant karyotype--results from a prospective pilot study (English)

1 reference

31 July 2017

0 references

7

C Haferlach

1 reference

31 July 2017

C Schmid

1

1 reference

31 July 2017

M Schleuning

2

1 reference

31 July 2017

J Tischer

3

1 reference

31 July 2017

E Holler

4

1 reference

31 July 2017

K-H Haude

5

1 reference

31 July 2017

J Braess

6

1 reference

31 July 2017

H Baurmann

8

1 reference

31 July 2017

D Oruzio

9

1 reference

31 July 2017

J Hahn

10

1 reference

31 July 2017

K Spiekermann

11

1 reference

31 July 2017

G Schlimok

12

1 reference

31 July 2017

R Schwerdtfeger

13

1 reference

31 July 2017

T Buechner

14

1 reference

31 July 2017

W Hiddemann

15

1 reference

31 July 2017

H-J Kolb

16

1 reference

31 July 2017

language of work or name

English

0 references

publication date

28 February 2011

1 reference

Bone Marrow Transplantation

31 July 2017

published in

1 reference

31 July 2017

volume

47

1 reference

31 July 2017

issue

1

1 reference

31 July 2017

page(s)

46-53

1 reference

Cytogenetic, molecular genetic, and clinical characteristics of acute myeloid leukemia with a complex karyotype

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.15

Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.15

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.15

Interactive diagnostics in the indication to allogeneic SCT in AML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.15

Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.15

Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.15

Sequential regimen of chemotherapy, reduced-intensity conditioning for allogeneic stem-cell transplantation, and prophylactic donor lymphocyte transfusion in high-risk acute myeloid leukemia and myelodysplastic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.15

Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.15

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.15

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.15

Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.15

Comparison of chromosome banding analysis, interphase- and hypermetaphase-FISH, qualitative and quantitative PCR for diagnosis and for follow-up in chronic myeloid leukemia: a study on 350 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.15

Patients with de novo acute myeloid leukaemia and complex karyotype aberrations show a poor prognosis despite intensive treatment: a study of 90 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.15

Long-term outcome after allogeneic hematopoietic stem cell transplantation for advanced stage acute myeloblastic leukemia: a retrospective study of 379 patients reported to the Société Française de Greffe de Moelle (SFGM).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.15

Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CR1): an intention-to-treat analysis of the EORTC/GIMEMAAML-10 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.15

Current status of blood and marrow transplantation for patients with AML

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.15

7 January 2021

Donor lymphocyte infusion in the treatment of first hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia: a retrospective risk factors analysis and comparison with other strategies by the EBMT Acute

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.15

7 January 2021

Reduced intensity conditioning allows for up-front allogeneic hematopoietic stem cell transplantation after cytoreductive induction therapy in newly-diagnosed high-risk acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.15

7 January 2021

Monosomal karyotype in acute myeloid leukemia: a better indicator of poor prognosis than a complex karyotype

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.15

7 January 2021

Identifiers

DOI

10.1038/BMT.2011.15

1 reference

Dimensions Publication ID

31 July 2017

1015670746

0 references

1 reference